Beta-carboline hydroxamic acid compounds represented by formula (I)
##STR1##
are described. The beta-carboline hydroxamic acid compounds and compositions
containing those compounds may be used to inhibit or modulate the activity of HIV
integrase enzyme and to treat HIV integrase-mediated diseases and conditions.